Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Bennett

Showing results (111-120 of 164) with videos related to

Pageof 17
Sort By:
Biorxiv : the Preprint Server for Biology|January 23, 2024
Mixed Alkyl/Aryl Phosphonates Identify Metabolic Serine Hydrolases as Antimalarial TargetsJohn M Bennett, Sunil K Narwal, Stephanie Kabeche, et al.
Cell Chemical Biology|August 13, 2024
Mixed alkyl/aryl phosphonates identify metabolic serine hydrolases as antimalarial targetsJohn M Bennett, Sunil K Narwal, Stephanie Kabeche, et al.
Cancer|March 15, 2006
Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized studyHagop Kantarjian, Jean-Pierre J Issa, Craig S Rosenfeld, et al.
ACS Infectious Diseases|September 15, 2023
Covalent Macrocyclic Proteasome Inhibitors Mitigate Resistance in <i>Plasmodium falciparum</i>John M Bennett, Kurt E Ward, Ryan K Muir, et al.
ACS Infectious Diseases|February 11, 2021
Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19Kas Steuten, Heeyoung Kim, John C Widen, et al.
Blood|April 13, 2006
Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasiaBruce D Cheson, Peter L Greenberg, John M Bennett, et al.
American Journal of Hematology|June 16, 2018
Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experienceChezi Ganzel, Zhuoxin Sun, Larry D Cripe, et al.
Haematologica|October 8, 2008
Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblastsGhulam J Mufti, John M Bennett, Jean Goasguen, et al.
Blood|August 2, 2011
Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997Mitchell R Smith, Donna Neuberg, Ian W Flinn, et al.
Haematologica|November 24, 2018
Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900Hugo F Fernandez, Zhuoxin Sun, Mark R Litzow, et al.
Pageof 17

Showing results (111-120 of 164) with videos related to

Sort By:
Pageof 17
Biorxiv : the Preprint Server for Biology|January 23, 2024
Mixed Alkyl/Aryl Phosphonates Identify Metabolic Serine Hydrolases as Antimalarial TargetsJohn M Bennett, Sunil K Narwal, Stephanie Kabeche, et al.
Cell Chemical Biology|August 13, 2024
Mixed alkyl/aryl phosphonates identify metabolic serine hydrolases as antimalarial targetsJohn M Bennett, Sunil K Narwal, Stephanie Kabeche, et al.
Cancer|March 15, 2006
Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized studyHagop Kantarjian, Jean-Pierre J Issa, Craig S Rosenfeld, et al.
ACS Infectious Diseases|September 15, 2023
Covalent Macrocyclic Proteasome Inhibitors Mitigate Resistance in <i>Plasmodium falciparum</i>John M Bennett, Kurt E Ward, Ryan K Muir, et al.
ACS Infectious Diseases|February 11, 2021
Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19Kas Steuten, Heeyoung Kim, John C Widen, et al.
Blood|April 13, 2006
Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasiaBruce D Cheson, Peter L Greenberg, John M Bennett, et al.
American Journal of Hematology|June 16, 2018
Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experienceChezi Ganzel, Zhuoxin Sun, Larry D Cripe, et al.
Haematologica|October 8, 2008
Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblastsGhulam J Mufti, John M Bennett, Jean Goasguen, et al.
Blood|August 2, 2011
Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997Mitchell R Smith, Donna Neuberg, Ian W Flinn, et al.
Haematologica|November 24, 2018
Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900Hugo F Fernandez, Zhuoxin Sun, Mark R Litzow, et al.
Pageof 17